Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

US Patent 10947198 · Granted Mar 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reset-type charge-sensitive amplifying circuit, and method for amplifying and re2025
Electromagnetic field simulation method based on face-centered cubic and subgrid2025
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms2025
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms2025
Small molecule inhibitors of the BfrB:Bfd interaction2025
Small molecule inhibitors of the BfrB:Bfd interaction2025
Host rate adjustment using free space values2025
Media management2025
Mixed write cursor for block stripe writing2024
Cannabigerol derivatives and use thereof as cannabinoid receptor modulators2024
Cannabinoid derivatives2024
Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substitut2024